Gw Henssler & Associates 13F: Cuts Amdocs (DOX) Stake by $8.3M
Key Points
- Gw Henssler & Associates cut its stake in Amdocs by 145,166 shares, resulting in a 96.3% decrease in its position.
- Gw Henssler & Associates held 5,618 $DOX shares at quarter end, down 96.27% from the prior quarter.
- The firm's total reported value for Amdocs now stands at $321,238, which is just 0.04% of its overall portfolio.
- Amdocs shares recently traded at about $62.68, which is 26.8% below its 52-week high of $85.63.
Get Amdocs Limited text alerts
We text you when insiders, Congress, analysts or big funds move on $DOX.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Amdocs Limited alert may contain errors. Disclosures
On October 26, 2026, Gw Henssler & Associates reduced its stake in Amdocs Limited (DOX) by 145,166 shares. This cut brought its total holdings down to 5,618 shares, valued at approximately $321,238, according to the firm's latest Form 13F filing with the SEC.
This reduction represents a 96.3% decrease in Gw Henssler's position in Amdocs. The firm reported a total value of $758.9 million across its 224 positions, with Amdocs making up just 0.04% of that portfolio. The dollar size of this cut, at about $8.3 million, reflects a significant shift in the firm's investment strategy.
DOX
Amdocs Limited
Where Amdocs Fits in Gw Henssler's Portfolio
Amdocs is ranked 37th among Gw Henssler's holdings. The drastic reduction in shares indicates a significant strategic change, especially considering it was once a much larger position.
Amdocs Limited Stock Down 0.1%
As of October 26, 2026, Amdocs shares closed at $62.68. This price is about equal to the recent trading price, but it is still below its 200-day moving average by 0.6%. Currently, the stock is 26.8% off its 52-week high of $85.63, reflecting some challenges in the current market.
Recent Earnings
Amdocs reported trailing twelve-month revenue of approximately $4.65 billion, with a net margin of 9.8%. Its earnings per share (EPS) stood at $4.21. The next earnings report is scheduled for November 3, 2026, which may provide further insight into the company's performance and future outlook.
Dividend
Amdocs pays an annual dividend of $2.28 per share, yielding about 3.63%. The firm has a dividend payout ratio of 52.1%, indicating a balanced approach to rewarding shareholders while reinvesting in growth.
Analysts Set New Price Targets
No recent analyst ratings or price targets were noted for Amdocs in this filing period.
About Amdocs
Amdocs Limited provides software and services to various service providers, including those in communications and media. Their offerings include cloud solutions and customer experience tools enhanced with AI technology. This positioning is crucial as the industry evolves with increasing digital demands.
Bottom Line
Investors should keep an eye on Amdocs' upcoming earnings report on November 3, 2026, for further insights into the company's performance. Additionally, monitor any further filings from Gw Henssler and other institutional investors as they adjust their positions in response to market conditions.
Related Filing Alerts
Source: Gw Henssler & Associates's 13F filing on $DOX (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts